Viewing StudyNCT00000687



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00000687
Status: COMPLETED
Last Update Posted: 2021-11-03
First Post: 1999-11-02

Brief Title: Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposis Sarcoma
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Sarcoma Kaposi
Keywords:
Name View
Zidovudine View
Interferon Alfa-2a View
Drug Evaluation View
Drug Therapy Combination View
Acquired Immunodeficiency Syndrome View